Recovery of memory retention after anesthesia with remimazolam: an exploratory, randomized, open, propofol-controlled, single-center clinical trial
- PMID: 37438459
- PMCID: PMC10338417
- DOI: 10.1186/s40981-023-00635-7
Recovery of memory retention after anesthesia with remimazolam: an exploratory, randomized, open, propofol-controlled, single-center clinical trial
Abstract
Purpose: Remimazolam, a newly developed ultra-short-acting benzodiazepine, provides early recovery of consciousness but its effects on memory recovery are unclear. This study examined memory recovery after emergence from general anesthesia using remimazolam.
Methods: Seventy-four patients undergoing breast surgery between October 2021 and March 2022 were enrolled and randomly assigned to receive propofol (control group) or remimazolam as general anesthetic during surgery. The primary endpoint was the number of posters patients remembered 24 h after surgery (among four posters shown after recovering from anesthesia) as an assessment of memory retention. The secondary endpoints were the recall of a numeric character patients had been shown just before anesthetic induction, as an assessment of retrograde amnesia 24 h after surgery.
Results: Sixty-six patients (propofol, 32; remimazolam, 34) were assessed. Patients in the remimazolam group remembered significantly fewer posters shown to them after surgery than those in the propofol group (0 [0 - 2] vs. 2 [1 - 3], p < 0.001). In the remimazolam group, the patients who received flumazenil remembered a higher number of posters than those who did not receive flumazenil (3 [1 - 4] vs. 0 [0 - 0], p < 0.001). All patients remembered all events that occurred during the preoperative period as well as the numeric character.
Conclusion: Patients recovering from remimazolam anesthesia without receiving flumazenil do not remember events after regaining consciousness. IRB: Kyushu University School of Medicine Hospital Institutional Review Board (IRB) (approval number: 20212006).
Trial registration: This clinical trial was registered with the University Hospital Medical Information Network (UMIN) Center on September 28, 2021 (UMIN-CTR: UMIN000045593).
Implication statement: Memory recovery is slower following emergence from remimazolam than from propofol anesthesia.
Keywords: Amnesia; Anesthesia; Memory; Propofol; RCT; Remimazolam.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Comparison of Remimazolam-Flumazenil versus Propofol for Recovery from General Anesthesia: A Systematic Review and Meta-Analysis.J Clin Med. 2023 Nov 26;12(23):7316. doi: 10.3390/jcm12237316. J Clin Med. 2023. PMID: 38068368 Free PMC article. Review.
-
The effect of remimazolam on postoperative memory retention and delayed regeneration in breast surgery patients: Rationale and design of an exploratory, randomized, open, propofol-controlled, single-center clinical trial: A study protocol.Medicine (Baltimore). 2021 Dec 3;100(48):e27808. doi: 10.1097/MD.0000000000027808. Medicine (Baltimore). 2021. PMID: 35049181 Free PMC article.
-
Comparison of Remimazolam Tosilate and Propofol Sedation on the Early Postoperative Quality of Recovery in Patients Undergoing Day Surgery: A Prospective Randomized Controlled Trial.Drug Des Devel Ther. 2024 May 23;18:1743-1754. doi: 10.2147/DDDT.S456675. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38803562 Free PMC article. Clinical Trial.
-
Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial.Medicine (Baltimore). 2023 Nov 17;102(46):e36081. doi: 10.1097/MD.0000000000036081. Medicine (Baltimore). 2023. PMID: 37986333 Free PMC article. Clinical Trial.
-
The use of remimazolam versus propofol for induction and maintenance of general anesthesia: A systematic review and meta-analysis.Front Pharmacol. 2023 Feb 6;14:1101728. doi: 10.3389/fphar.2023.1101728. eCollection 2023. Front Pharmacol. 2023. PMID: 36814492 Free PMC article.
Cited by
-
Comparing Cognitive Recovery of Remimazolam versus Propofol in Elderly Patients Undergoing Colonoscopy: A Randomized Controlled Trial.Clin Interv Aging. 2024 Dec 16;19:2133-2143. doi: 10.2147/CIA.S490330. eCollection 2024. Clin Interv Aging. 2024. PMID: 39712634 Free PMC article. Clinical Trial.
-
Current and Developing Approaches for Facilitating Emergence from General Anesthesia.Anesthesiology. 2025 Oct 1;143(4):1049-1089. doi: 10.1097/ALN.0000000000005600. Epub 2025 Sep 9. Anesthesiology. 2025. PMID: 40923827 Review.
-
Remimazolam Pilot for Office-Based Dental Sedation: Adverse Events, Awareness and Outcomes.J Clin Med. 2023 Nov 25;12(23):7308. doi: 10.3390/jcm12237308. J Clin Med. 2023. PMID: 38068360 Free PMC article.
-
Comparison of Remimazolam-Flumazenil versus Propofol for Recovery from General Anesthesia: A Systematic Review and Meta-Analysis.J Clin Med. 2023 Nov 26;12(23):7316. doi: 10.3390/jcm12237316. J Clin Med. 2023. PMID: 38068368 Free PMC article. Review.
-
An ultra-short-acting benzodiazepine in thalamic nucleus reuniens undermines fear extinction via intermediation of hippocamposeptal circuits.Commun Biol. 2024 Jun 14;7(1):728. doi: 10.1038/s42003-024-06417-w. Commun Biol. 2024. PMID: 38877285 Free PMC article.
References
LinkOut - more resources
Full Text Sources